European Medicines Agency guidelines to increase the pace of biosimilar development.
Lisa
L
Parks
D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D055808:Drug Discovery; D005060:Europe; D006801:Humans; D007880:Legislation, Drug / Q000458:organization & administration
D059451:Biosimilar Pharmaceuticals